Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0TC4I
|
|||
Former ID |
DNC010027
|
|||
Drug Name |
(S)-2-amino-4-hydroxy-N-(4-octylphenyl)butanamide
|
|||
Synonyms |
CHEMBL583979; (S)-2-amino-4-hydroxy-N-(4-octylphenyl)butanamide; SCHEMBL1311702; QJTVTVAQRCRXSM-KRWDZBQOSA-N
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C18H30N2O2
|
|||
Canonical SMILES |
CCCCCCCCC1=CC=C(C=C1)NC(=O)C(CCO)N
|
|||
InChI |
1S/C18H30N2O2/c1-2-3-4-5-6-7-8-15-9-11-16(12-10-15)20-18(22)17(19)13-14-21/h9-12,17,21H,2-8,13-14,19H2,1H3,(H,20,22)/t17-/m0/s1
|
|||
InChIKey |
QJTVTVAQRCRXSM-KRWDZBQOSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Sphingosine kinase 2 (SPHK2) | Target Info | Inhibitor | [1] |
BioCyc | Sphingosine and sphingosine-1-phosphate metabolism | |||
KEGG Pathway | Sphingolipid metabolism | |||
Metabolic pathways | ||||
Calcium signaling pathway | ||||
Sphingolipid signaling pathway | ||||
VEGF signaling pathway | ||||
Fc gamma R-mediated phagocytosis | ||||
Tuberculosis | ||||
Panther Pathway | Angiogenesis | |||
VEGF signaling pathway | ||||
Pathwhiz Pathway | Sphingolipid Metabolism | |||
Pathway Interaction Database | IL12-mediated signaling events | |||
Ceramide signaling pathway | ||||
Sphingosine 1-phosphate (S1P) pathway | ||||
Reactome | Sphingolipid de novo biosynthesis | |||
WikiPathways | Signal Transduction of S1P Receptor | |||
Sphingolipid Metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | Discovery of novel sphingosine kinase 1 inhibitors. Bioorg Med Chem Lett. 2009 Nov 1;19(21):6119-21. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.